Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 21, 2020 - Issue 1-2
Submit an article Journal homepage
909
Views
5
CrossRef citations to date
0
Altmetric
Epidemiology

An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland

Elizabeth Elliott1 Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK, ;2 Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK, ;3 Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK, ;4 Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK,
,
Judith Newton1 Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK, ;2 Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK, ;3 Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK, ;4 Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK, ;5 Clinical Audit Research and Evaluation for Motor Neurone Disease, Scotland, UK, and
,
Phillipa Rewaj1 Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK, ;2 Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK,
,
Jenna M. Gregory1 Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK, ;3 Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK, ;4 Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK,
,
Lynda Tomarelli1 Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK, ;2 Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK,
,
Shuna Colville1 Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK, ;2 Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK, ;3 Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK, ;4 Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK, ;5 Clinical Audit Research and Evaluation for Motor Neurone Disease, Scotland, UK, and
,
Siddharthan Chandran1 Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK, ;2 Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK, ;3 Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK, ;4 Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK, ;5 Clinical Audit Research and Evaluation for Motor Neurone Disease, Scotland, UK, and
,
Suvankar Pal1 Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK, ;2 Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK, ;3 Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK, ;4 Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK, ;5 Clinical Audit Research and Evaluation for Motor Neurone Disease, Scotland, UK, and ;6 Department of Neurology, NHS Forth Valley, Stirling, UKCorrespondence[email protected]
& On behalf of the Care-Mnd Consortium show all
Pages 116-122 | Received 02 Mar 2019, Accepted 16 Sep 2019, Published online: 09 Oct 2019

References

  • Martin S, Trevor-Jones E, Khan S, Shaw K, Marchment D, Kulka A, et al. The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:569–75.
  • Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661–70.
  • Crockford CE, Newton JE, Lonergan KE, Chiwera TE, Booth TE, Chandran SE, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370–80.
  • Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
  • Makkonen T, Ruottinen H, Puhto R, Helminen M, Palmio J. Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms. Int J Lang Commun Disord. 2018;53:385–92. 2018;
  • Beukelman D, Fager S, Nordness A, van den Bergh P. Communication support for people with ALS. Neurol Res Int. 2011;2011:1.
  • Brownlee AM, Bruening LM. Methods of communication at end of life for the person with amyotrophic lateral sclerosis. Top Lang Disord. 2012;32:168–85.
  • Hecht M, Hillemacher T, Gräsel E, Tigges S, Winterholler M, Heuss D, et al. Subjective experience and coping in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:225–31.
  • Abrahams S, Goldstein LH, Simmons A, Brammer M, Williams SCR, Giampietro V, et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain. 2004;127:1507–17.
  • Beukelman DR, Fager S, Ball L, Dietz A. AAC for adults with acquired neurological conditions: a review. Augment Altern Comm. 2007;23:230–42.
  • Creer S, Enderby P, Judge S, John A. Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need. Int J Lang Commun Disord. 2016;51:639–53.
  • Iacono T, Lyon K, West D. Non-electronic communication aids for people with complex communication needs. Int J Speech Lang Pathol. 2011;13:399–410.
  • Mckelvey M, Evans DL, Kawai N, Beukelman D. Communication styles of persons with ALS as recounted by surviving partners. Augment Altern Commun. 2012;28:232–42.
  • Körner S, Siniawski M, Kollewe K, Rath KJ, Krampfl K, Zapf A, et al. Speech therapy and communication device: impact on quality of life and mood in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:20–5.
  • Ball LJ, Beukelman DR, Anderson E, Bilyeu DV, Robertson J, Pattee GL. Duration of AAC technology use by persons with ALS.(augmentative and alternative communication) (amyotrophic lateral sclerosis). J Med Speech Lang Pathol. 2007;15:371–81.
  • Universal Declaration of Human Rights. United Nations, 217 (III) A, 1948, Paris, art. 19 [online]. Available at: http://www.un.org/en/universal-declaration-human-rights/. Accessed May 14, 2018.
  • Government, S. (2018). Part 4 of the Health (Tobacco, Nicotine etc. and Care) (Scotland) Act 2016 [online]. Edinburgh. Available at: http://www.legislation.gov.uk/asp/2016/14/part/4/enacted. Accessed April 16 2018.
  • NICE. (2016). Motor neurone disease: assessment and management. NICE guideline (NG42) [online]. Available at: http://www.nice.org.uk/Guidance/NG42. Accessed April 23 2018.
  • Brooks BR, Sanjak M, Ringel S, England J, Brinkmann J, Pestronk A, et al. The amyotrophic lateral sclerosis functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141–7.
  • R Core Team. (2013). R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. URL http://www.R-project.org/
  • Rong P, Yunusova Y, Wang J, Zinman L, Pattee GL, Berry JD, et al. Predicting speech intelligibility decline in amyotrophic lateral sclerosis based on the deterioration of individual speech subsystems. PLoS One. 2016;11:e0154971.
  • Hobson EV, Fazal S, Shaw PJ, McDermott CJ. “Anything that makes life’s journey better.” Exploring the use of digital technology by people living with motor neurone disease. Amyotroph Lateral Scler Frontotemporal Degener. 2017; 18:378–87.
  • Funke A, Spittel S, Grehl T, Grosskreutz J, Kettemann D, Petri S, et al. Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:342–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.